
Ecosprin 75 mg Tablet
Salt Composition: Aspirin (75mg)
Expiry Date: 01/2028
Inclusive of all taxes
14 Tablets
About The Product
Prevents clot formation, heart attack, stroke
Description
Ecosprin 75 mg Tablet is a doctor prescribed anti platelet agent that prevent blood clots, reducing risks of heart attacks, strokes, and angina in patients with cardiovascular conditions.
Ecosprin 75mg Tablet contains 75mg of Aspirin prevent platelet aggregation and reduce blood clot formation.
Indication
Prevent Blood Clots
Common Side Effects
- Ecosprin 75mg Tablet is an allopathic medication that can only be purchased with a prescription.
- This is a component of a chemical based medication.
- Like any other chemical-based drug, its chemical-based formula causes multiple negative effects.
- See your physician if these side effects persist for an extended period of time. ● Heat Burn ● Nausea ● Stomach Upset ● Abdominal pain ● Increased Bleeding Risk ● Gastrointestinal Bleeding ● Severe Allergic Reactions ● Reye's Syndrome ● Hemorrhagic Stroke
Dosage And Administration
- Ecosprin 75mg Tablet is taken orally.
- Tablet is swallowed as it is with the help of water.
- It can be taken after or before food consumption (Prefer After Food).
- Avoid crushing, chewing, breaking or biting of tablet to maintain its efficacy.
- In general, Ecosprin 75mg Tablet dosage in just one tablet at same time every day.
- For more personalized assistance and exact dosage, talk to your doctor about the same.
Mechanism Of Action
Ecosprin 75mg Tablet contains 75mg of Aspirin that is an antiplatelet active ingredient.
Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1) enzyme in platelets through acetylation, blocking thromboxane A2 (TXA2) production to prevent platelet aggregation and reduce blood clot formation.
Safety Advice
Faqs
Ecosprin 75mg Tablet contains Aspirin that blocks thromboxane A2 (TXA2) production to prevent platelet aggregation and reduce blood clot formation.
References
• Thun, M. J., Namboodiri, M.
M., Calle, E. E., Flanders, W.
D., & Heath Jr, C. W.
(1993). Aspirin use and risk of fatal cancer.
Cancer research, 53(6), 1322-1327. • Patrono, C. (2001).
Aspirin: new cardiovascular uses for an old drug. The American journal of medicine, 110(1), S62-S65. • Yeomans, N.
D. (2011).
Aspirin: old drug, new uses and challenges. Journal of gastroenterology and hepatology, 26(3), 426-431. • Vane, J.
R., & Botting, R. M.
(1997, June). Mechanism of action of aspirin-like drugs.
In Seminars in arthritis and rheumatism (Vol. 26, pp.
2-10). WB Saunders.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
